Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberte Paclitaxel-Eluting Stents

被引：0
|
作者：
Kereiakes, Dean J. [1 ]
Cannon, Louis A. [2 ]
Ormiston, John A. [3 ]
Wang, Hong [4 ]
Underwood, Paul L. [4 ]
Dawkins, Keith D. [4 ]
机构：
[1] Christ Hosp, Heart & Vasc Ctr, Lindner Ctr Res & Educ, Cincinnati, OH 45219 USA
[2] No Michigan Reg Hosp, Cardiac Vasc Res Ctr No Michigan, Petoskey, MI USA
[3] Mercy Hosp, Auckland, New Zealand
[4] Boston Sci Corp, Marlborough, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 58卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B64 / B64
页数：1
相关论文
共 50 条
  • [31] Two-year outcomes in real world experience with TAXUS paclitaxel-eluting stent in a prospective, multicenter, consecutively-enrolling US registry: ARRIVE 1
    Lasala, John M.
    Mann, J. Tift
    Armstrong, Brian
    Kellet, Mirle
    Mascioli, Stephen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 8B - 8B
  • [32] Durability of the polymer-based, paclitaxel-eluting TAXUS stent in key patient subsets: Two-year results from the TAXUS-IV trial
    Ellis, S
    Stone, GW
    Cox, DA
    Hermiller, J
    O'Shaughnessey, CD
    Mann, JT
    Turco, M
    Caputo, R
    Bergin, PJ
    Greenberg, J
    Raizner, A
    Popma, JJ
    Russell, ME
    Russell, ME
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 49A - 49A
  • [33] Paclitaxel-eluting stents versus everolimus-eluting coronary stents in a diabetic population: two-year follow-up of the TUXEDO-India trial
    Kaul, Upendra
    Bhagwat, Ajit
    Pinto, Brian
    Goel, Praveen K.
    Jagtap, Prashant
    Sathe, Shireesh
    Wander, Gurpreet S.
    Arambam, Priyadarshini
    Bangalore, Sripal
    EUROINTERVENTION, 2017, 13 (10) : 1194 - 1201
  • [34] Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: Two-year subgroup analysis of the ZEST randomized trial
    Jang, Sun-Joo
    Park, Duk-Woo
    Kim, Won-Jang
    Kim, Young-Hak
    Yun, Sung-Cheol
    Kang, Soo-Jin
    Lee, Seung-Whan
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (07) : 1106 - 1114
  • [35] Two-year outcomes of everolimus vs. paclitaxel-eluting stent for the treatment of unprotected left main lesions: a propensity score matching comparison of patients included in the French Left Main Taxus (FLM Taxus) and the LEft MAin Xience (LEMAX) registries
    Moynagh, Anouska
    Salvatella, Neus
    Harb, Talal
    Darremont, Olivier
    Boudou, Nicolas
    Dumonteil, Nicolas
    Lefevre, Thierry
    Carrie, Didier
    Louvard, Yves
    Leymarie, Jean-Louis
    Chevalier, Bernard
    Morice, Marie-Claude
    Garot, Philippe
    EUROINTERVENTION, 2013, 9 (04) : 452 - 462
  • [36] Four-year clinical outcomes of the polymer-based paclitaxel-eluting TAXUS stent: The TAXUS IV trial
    Hermiller, James B.
    Ellis, Stephen G.
    Cox, Dovid A.
    O'Shaughnessy, Charles D.
    Mann, Tift
    Turco, Mark
    Caputo, Ronald
    Bergin, Patrick J.
    Greenberg, Joel D.
    Raizner, Albert E.
    Popma, Jeffrey J.
    Koglin, Joerg
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 27M - 27M
  • [37] Randomized Comparison of Everolimus-eluting and Paclitaxel-eluting Stents: Pooled analysis of Two-Year Clinical Follow-up from the SPIRIT II and III Trials
    Onuma, Yoshinobu
    Serruys, Patrick W.
    Kukureja, Neville
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A9 - A10
  • [38] Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial
    Kedhi, Elvin
    Gomes, Marc
    Joesoef, Kaiyum Sheik
    Wassing, Jochem
    Goedhart, Dick
    McFadden, Eugene
    Smits, Pieter C.
    EUROINTERVENTION, 2012, 7 (12) : 1376 - 1385
  • [39] Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents
    Kang, W. C.
    Ahn, T. H.
    Moon, C. I.
    Han, S. H.
    Shin, E. K.
    Kim, J-S
    Ko, Y-G
    Choi, D.
    Jang, Y.
    Kim, B-K
    Oh, S. J.
    Jeon, D. W.
    Yang, J-Y
    HEART, 2009, 95 (12) : 970 - 975
  • [40] The prospective, randomized comparison of promus everolimus-eluting and TAXUS liberte paclitaxel-eluting stent systems in patients with coronary artery disease: the PROMISE study
    Cho, C. H. O.
    Lee, H. W.
    Lee, H. W.
    Kim, U.
    Park, J. S.
    Kim, Y. J.
    Jung, M. H.
    Cho, M. C.
    Bae, J. H.
    Kang, S. W.
    EUROPEAN HEART JOURNAL, 2013, 34 : 544 - 544
12345